Introduction
Methods
Results
Conclusion
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryReferences
- Perioperative Mortality Rate (POMR): a global indicator of access to safe surgery and anaesthesia.World J Surg. 2015; 39: 856-864
- Standardised metrics for global surgical surveillance.Lancet. 2009; 374: 1113-1117
- Global Surgery 2030: Evidence and solutions for achieving health, welfare and economic development.Lancet. 2015; 385 (Global Surgery special issue) (Published Online April 27, 2015): S29https://doi.org/10.1016/S0140-6736(15)60160-X
- Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis.Lancet. 2012; 380: 1075-1081
- A surgical safety checklist to reduce morbidity and mortality in a global population.N Engl J Med. 2009; 360: 491-499
- Use and definitions of perioperative mortality rates in low-income and middle-income countries: a systematic review.Lancet. 2015; 385 (Global Surgery special issue): S29
- Mortality after surgery in Europe: a 7 day cohort study.Lancet. 2012; 380: 1059-1065
- Mortality after surgery in Europe.Lancet. 2013; 381: 369
- Mortality after surgery in Europe.Lancet. 2013; 381: 369
- Mortality after surgery in Europe.Lancet. 2013; 381: 369-370
- Mortality after surgery in Europe.Lancet. 2013; 381: 370
- Mortality after surgery in Europe.Lancet. 2013; 381: 370
- Perioperative Mortality in New Zealand: Third Report of the Perioperative Mortality Review Committee.Health Quality and Safety Commission, Wellington2014
Article info
Publication history
Footnotes
This work was supported by the Lancet Commission on Global Surgery. The authors acknowledge the assistance of the Perioperative Mortality Review Committee and Health Quality and Safety Commission, Wellington, in provision of New Zealand data. R.L.G. is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council. No funding was received for this work. Study design: D.A.W. and R.L.G.; data collection: R.A., P.H., G.L.L., D.S., L.W., D.L.C., and D.A.W.; data analysis: C.L.P., P.H., and R.L.G.; data interpretation: all authors; writing and editing: all authors.